InvestorsHub Logo
Followers 2
Posts 21
Boards Moderated 0
Alias Born 01/06/2014

Re: None

Wednesday, 04/02/2014 1:57:31 PM

Wednesday, April 02, 2014 1:57:31 PM

Post# of 6389
BPTH is oversold. Good discount price for entry or averaging down. I do not understand why anyone would sell if they are averaged below the current price. Once the last person of the final Phase I cohort completes the treatment, they are immediately ready to jump into Phase II. IMO, once that happens, we are back in the $4+ territory right away.

Bio-Path Holdings Inc (NASDAQ:BPTH) weekly performance is -16.30%. On last trading day company shares ended up $2.26. Bio-Path Holdings Inc (NASDAQ:BPTH) distance from 50-day simple moving average is -41.63%. Analysts mean target price for the company is $3.00.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News